Wellington Management Company »

Phathom Pharmaceuticals shares owned by Wellington Management Company

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 154k 9.13
2023-09-30 $1.0M 100k 10.37
2023-06-30 $1.4M 98k 14.32

More positions owned by Wellington Management Company

Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
Pfizer (PFE)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Danaher Corporation (DHR)
NVIDIA Corporation (NVDA)
Procter & Gamble Company (PG)
TJX Companies (TJX)
Mastercard Incorporated Cl A (MA)

View all positions for Wellington Management Company

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Carlyle
NEA Management Company
Vanguard Group
Avidity Partners Management
Gilder, Gagnon, Howe & Co
683 Capital Management
Decheng Capital
Newtyn Management
Jacobs Levy Equity Management
Kennedy Capital Management
Jennifer Ranahan
Propel Bio Management
Checkpoint Capital

View all funds holding Phathom Pharmaceuticals